7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Cancer Care

How Neck Cancer Treatment Is Planned When Lymph Nodes Are Involved

24 min read
How Neck Cancer Treatment Is Planned When Lymph Nodes Are Involved

Key Takeaways

  • Lymph node involvement in the neck is regional disease, staged and treated separately from distant metastasis to lungs, bones or liver.
  • The N stage records the number, size and side of involved nodes plus extranodal extension, and that last finding is the single feature most likely to add chemotherapy to postoperative radiotherapy.
  • HPV is linked to about 70 percent of oropharyngeal cancers in the United States, and HPV-positive disease is staged on its own scale because it behaves differently.
  • The neck is divided into six levels with predictable drainage routes, which is why a selective neck dissection removes only the levels at risk and spares the shoulder nerve, jugular vein and neck muscle when possible.
  • Radiotherapy for the neck is given in daily weekday sessions over a course that can run up to about seven weeks, with the sorest period often falling in the final week and the weeks just after.
  • A node still present after chemoradiation is usually assessed with a PET-CT at around 12 weeks rather than immediate surgery, an approach supported by a large randomized trial.
Quick Answer

When neck cancer involves lymph nodes, a multidisciplinary team plans treatment after biopsy, imaging and staging establish how many nodes are affected, their size, which side they sit on and whether cancer has broken through the node capsule. The team then chooses surgery, radiotherapy, chemoradiation or a sequence of these, matched to the primary tumor site, HPV status, overall fitness and the patient's own priorities.

The surgeon pulls a sheet of paper toward her and sketches a neck in profile, then divides it into six numbered zones with quick pencil strokes. She circles zone two. That, she says, is where the biopsy came back positive. The patient across the desk has stopped hearing individual words by now; what registers is that the lump he found while shaving has a map, and the map has a plan attached to it.

This is what neck cancer treatment planning looks like from the inside: not one decision but a chain of them, each resting on a test result. Which node, how many, how big, which side, and whether the cancer has pushed through the node’s outer wall. Each answer narrows the options.

What follows walks through that chain in order, from the first needle biopsy to the follow-up scan months later, so that the pencil sketch makes sense before you are sitting across the desk yourself.

What lymph node metastasis in the neck actually means

A lymph node is a small, bean-shaped filter in the lymphatic system, the network of thin vessels that carries tissue fluid back toward the bloodstream. The neck holds a dense cluster of them because the mouth, throat, nose, salivary glands and skin of the head all drain through this corridor. When a cancer in any of those sites sheds cells into the lymph vessels, the first place those cells tend to lodge is a neck node. Doctors call this lymph node metastasis in the neck, or simply nodal disease.

Two things change once a node is involved. The first is stage: the cancer is no longer confined to its starting point, so it is classified and treated as regional disease. The second is geography. A tumor at the base of the tongue is a single target. A tumor plus three nodes on the same side of the neck is a wider field, and every part of that field has to be treated with intent, whether by a surgeon’s hand or a radiation beam.

It helps to be clear about what nodal spread is not. It is not distant metastasis, which means cancer in the lungs, bones or liver. Regional nodes remain part of the local territory, and in head and neck cancer they are routinely treated with the goal of controlling the disease rather than simply slowing it. The National Cancer Institute describes this regional drainage pattern as a defining feature of squamous cell carcinoma, the cell type behind most cancers of the mouth and throat.

Sometimes the node is the first and only sign. A painless lump below the jaw or along the side of the neck, noticed while shaving or buttoning a collar, is a classic way these cancers announce themselves. That lump is the reason the whole planning process exists.

How neck cancer treatment planning works when nodes are involved

No single doctor plans this alone. Head and neck cancer is one of the specialties where a multidisciplinary team meeting, often called a tumor board, is standard practice rather than a courtesy. The room typically holds a head and neck surgeon, a radiation oncologist, a medical oncologist, a radiologist who reads the scans, a pathologist who examined the biopsy, a speech and swallowing therapist, a dietitian, a dentist and a specialist nurse. The NHS describes this team approach as the normal route for anyone diagnosed with a head and neck cancer.

Doctor consulting with senior male patient at desk: How neck cancer treatment planning works when nodes are involved

The meeting works through a fixed sequence of questions. Is the diagnosis confirmed by tissue? Where is the primary tumor, and has it been found? What is the stage, counting both the tumor and the nodes? Is the person fit enough for a long operation or for a combined course of chemotherapy and radiation? What matters most to them: keeping their voice, swallowing normally, avoiding a tracheostomy, finishing treatment quickly?

Only then does the team choose a modality, meaning surgery, radiotherapy, chemoradiation or a planned sequence, and the order in which the pieces will happen. The plan is written down, explained to the patient, and treated as a first draft. If surgery comes first, the pathology report on the removed nodes often sends the case back to the same meeting, because findings under the microscope can change what comes next.

One point is worth holding onto. The person whose neck is on the table is part of this team. The clinicians bring evidence and experience; the patient brings values and limits. A plan that ignores either half tends to fail in practice.

Head and neck cancer staging: why the N stage carries so much weight

Staging uses the TNM system, three letters that each describe one dimension of the disease. T is the size and reach of the primary tumor. N describes the lymph nodes. M records whether cancer has traveled to distant organs. For head and neck cancer staging, the N component does an unusual amount of work, because it changes both the stage number and the intensity of treatment the guidelines recommend.

The N stage captures several details at once: how many nodes are involved, the largest node’s diameter, whether the nodes sit on the same side as the tumor or on both sides, and whether there is extranodal extension. That last term, often shortened to ENE, means the cancer has grown through the capsule of the node into surrounding tissue. A radiologist may suspect it on a scan; a pathologist confirms it after surgery. ENE is widely treated as a signal that one treatment alone may not be enough.

Human papillomavirus changed the staging rulebook. According to the National Cancer Institute, HPV is linked to roughly 70 percent of oropharyngeal cancers in the United States, meaning cancers of the tonsils and base of tongue. These cancers often present with large neck nodes and a small primary, yet they tend to respond differently from tobacco-related cancers. The current staging system therefore classifies HPV-positive oropharyngeal cancer on its own scale, and a person with several nodes may receive a lower stage than the same picture would have earned under the older rules.

Staging happens twice. The clinical stage, built from examination and imaging, guides the first decision. The pathological stage, built from what the surgeon removes, refines it. When the two disagree, the pathological stage usually wins.

Which tests come first, and what each one adds to the plan

The first task is proof. A lump in the neck is sampled with a fine needle or a slightly thicker core needle, usually guided by ultrasound so the clinician can watch the needle enter the node. The sample tells the pathologist what kind of cancer it is and, for cancers of the throat, whether it carries the p16 protein that serves as a marker for HPV. That one stain shifts the entire plan.

Doctor examining patient's neck in clinical setting: Which tests come first, and what each one adds to the plan

The second task is finding where the cancer started. Many primary tumors are visible in the clinic with a thin flexible scope passed through the nose. Others hide in the folds of the tonsil or the base of the tongue and require an examination under general anesthesia, with biopsies of any suspicious area. Imaging fills in the rest. CT or MRI of the neck shows the size of the tumor and nodes and how close they lie to the carotid artery and the base of the skull. A PET-CT, which highlights areas of high sugar uptake, searches the whole body for distant spread and can reveal a primary tumor that other tests missed.

Occasionally no primary is found at all. The National Cancer Institute’s guidance on metastatic squamous neck cancer with occult primary describes this situation and the stepwise search it triggers, including removal of the tonsils for examination, because the throat is the likeliest hidden source.

Alongside the cancer tests sit the fitness tests. A dental assessment, a baseline swallowing study, hearing and kidney checks if platinum chemotherapy is on the table, and a nutrition review. These are not formalities. Each one can change the recommended treatment, or delay its start until the body is ready.

Why the neck is mapped in levels before anything is decided

The pencil sketch with six numbered zones is the single most useful picture in this field. Surgeons divide each side of the neck into levels I through VI, named with Roman numerals. Level I sits under the chin and jaw. Levels II, III and IV run down the side of the neck along the large jugular vein, from just below the ear to the collarbone. Level V is the triangle at the back of the neck behind the big strap muscle. Level VI is the central compartment in front of the windpipe.

This matters because lymph drains along predictable routes. The front of the tongue and the floor of the mouth drain first into levels I and II. The tonsil and base of tongue favor levels II and III. The larynx tends toward levels II through IV. The thyroid drains into level VI. When the pathologist reports a positive node at level II, the team already has a strong clue about where the primary sits and which other levels are at risk.

The map does two jobs in planning. For surgery, it defines a selective neck dissection, in which only the levels most likely to harbor cancer are removed and the rest are left undisturbed. For radiotherapy, it defines the outline the radiation oncologist draws on the planning scan, so that at-risk levels receive a full dose while the spinal cord, salivary glands and swallowing muscles are shielded as far as possible.

The map also explains a decision that puzzles many patients: why a neck that feels and scans normal may still be treated. For some primary sites, the probability of microscopic deposits in a clinically negative neck is high enough that guidelines recommend elective treatment of the drainage levels anyway. Tumors near the midline may involve both sides.

Neck dissection surgery: what actually happens in the operating room

Neck dissection surgery is the removal of lymph nodes, along with the fatty tissue that surrounds them, from one or more levels of the neck. It is performed under general anesthesia, usually through a single curved incision placed in a skin crease so that it fades into the natural lines of the neck. The surgeon lifts the skin, identifies the major landmarks, and clears the planned levels while protecting the structures that run through them.

Three versions exist, and the names describe how much is taken. A selective neck dissection removes specific levels and spares the rest. A modified radical neck dissection clears levels I through V but preserves at least one of three structures: the sternocleidomastoid muscle that turns the head, the internal jugular vein, and the spinal accessory nerve that powers the shoulder. A radical neck dissection removes all three along with the nodes; it is now reserved for disease that has grown into those structures.

Every node removed goes to the pathologist, who counts them, measures them and looks for extranodal extension. That report becomes the pathological N stage and frequently decides whether radiotherapy follows.

For some small cancers of the mouth with a neck that appears clear, surgeons may offer a sentinel lymph node biopsy instead. A tracer injected around the tumor travels to the first draining node, which is removed and examined. If it is clear, a full dissection can often be avoided.

Risks are explained in advance and are concrete: bleeding, infection, numbness of the earlobe and neck skin, shoulder stiffness or weakness if the accessory nerve is bruised, a leak of lymphatic fluid called a chyle leak, and later swelling of the neck tissues known as lymphedema. The surgical team weighs each against the benefit of removing known disease.

Radiotherapy for neck lymph nodes: when it leads and when it follows

Radiotherapy uses focused beams of high-energy X-rays to damage the DNA of cancer cells so they cannot divide. For the neck, it is delivered from outside the body using a technique called intensity-modulated radiotherapy, which shapes the dose around the contours of the tumor and the involved levels while bending it away from the spinal cord and salivary glands. A custom plastic mask holds the head still in exactly the same position for every session.

Radiotherapy for neck lymph nodes plays one of two roles. As definitive treatment, it is the main therapy, often combined with chemotherapy, and is chosen when surgery would cost a person their voice box or their ability to swallow, or when the primary sits in the oropharynx where chemoradiation is a standard route. As adjuvant treatment, it follows surgery to clear microscopic cells left behind, and is commonly recommended when pathology shows several positive nodes, extranodal extension or cancer at the edge of what was removed.

The NHS explains that most courses run one session a day, Monday to Friday, with a full course lasting anywhere from one to seven weeks depending on the aim; head and neck courses sit at the longer end of that range. Each session takes minutes. The side effects build over the weeks: a sore mouth and throat, thick saliva followed by dryness, changes in taste, a skin reaction like sunburn, fatigue and difficulty swallowing that can make a temporary feeding tube necessary.

Before a single beam is delivered, a dentist reviews the teeth. Jawbone in the radiation field heals poorly for years afterward, so teeth that are likely to fail are usually removed first and the mouth allowed to heal, which is one of the most common reasons a start date moves.

When chemotherapy or immunotherapy joins the plan

Chemotherapy rarely treats a neck node on its own. Its usual job in this setting is to make radiotherapy work harder. A platinum-based drug, most often cisplatin, is given at intervals during the radiotherapy course; it interferes with the way cancer cells repair radiation damage, which is why the combination is called chemoradiation. Guidelines commonly reserve it for locally advanced disease, for example bulky nodes or nodes on both sides, and for postoperative cases where pathology shows extranodal extension or cancer at the surgical margin.

The price of that extra effect is a harder course. Nausea, kidney strain, hearing loss and low blood counts are recognized effects of platinum drugs, which is why hearing tests and kidney function checks are built into the planning stage. People who cannot safely receive platinum are sometimes offered a different radiosensitizer, or radiotherapy alone. That judgement belongs to the medical oncologist, who weighs fitness, age, other illnesses and the stage of the cancer.

Induction chemotherapy, meaning chemotherapy given before the main treatment to shrink the disease, is used in selected situations rather than routinely. Immune checkpoint inhibitors, a class of antibody drugs that release the brakes on the body’s own T cells, are part of guideline-based treatment for head and neck cancer that has come back or spread to distant organs. Their role earlier in the pathway is being studied in clinical trials, and anyone facing nodal disease can reasonably ask whether a trial is open to them.

Whatever is used, nothing in this section is a recommendation. The drugs are named so that the words on a treatment summary make sense. The choice, timing and dose sit with the prescribing team and are revisited at every stage.

Neck cancer treatment planning: who is offered surgery first, and who is asked to wait

Surgery-first pathways are common when the primary tumor would be removed by an operation anyway and the neck can be cleared through the same incision. That describes most cancers of the oral cavity, the salivary glands, the thyroid and the skin of the head and neck. It also fits nodes that are large and clearly resectable, where the team wants the pathology report in hand before deciding on radiotherapy.

Radiation-first or chemoradiation-first pathways are the standard approach for many cancers of the oropharynx and for larynx cancers where keeping the voice box is a realistic goal. HPV-positive disease, with its characteristic pattern of a small primary and prominent nodes, often falls here. Surgery is then held in reserve for any node that fails to clear.

Being asked to wait is not the same as being turned away, and it happens for predictable reasons. Dental extractions must heal before radiotherapy. A person who has lost weight may need a dietitian’s plan, or a feeding tube placed in advance, before a treatment that makes eating harder. Uncontrolled diabetes, heart disease or anemia may need attention before a long anesthetic. Someone who smokes is usually offered support to stop, because continued smoking blunts the effect of radiation and slows wound healing. Staging may simply be incomplete.

There is a second kind of waiting that surprises people. After chemoradiation, a node that is still palpable is not rushed to the operating room. A large UK trial published in the New England Journal of Medicine compared planned neck dissection against a PET-CT scan about 12 weeks after treatment, with surgery only if the scan remained suspicious, and found the watch-and-scan approach spared most people an operation without worse outcomes. Patience here is evidence-based.

Surgery-first or radiation-first? A side-by-side summary

The table below compresses the previous sections into the comparison patients most often ask for. It is a guide to how teams generally think, not a decision tool; the same clinical picture can be handled either way depending on the tumor site, the person’s fitness and what they want to protect.

Question Surgery-first pathway Radiation or chemoradiation-first pathway
Typical primary sites Oral cavity, salivary gland, thyroid, skin Oropharynx, many larynx and hypopharynx cancers
What happens to the nodes Removed in a selective or modified radical neck dissection Included in the radiation field; dissection only if they persist
How the N stage is confirmed Pathologist examines every removed node Imaging before treatment and PET-CT afterward
Common second step Radiotherapy, with chemotherapy if high-risk features are found Surgery for residual disease on a follow-up scan
Main functional concerns Shoulder movement, neck numbness, lymphedema Dry mouth, taste change, long-term swallowing, dental health
Often chosen when The primary is being removed anyway, or nodes are bulky but resectable Surgery would sacrifice voice or swallowing, or HPV-positive disease is likely

Two patterns stand out. First, the pathways converge: a surgery-first patient with extranodal extension will almost certainly meet the radiation oncologist later, and a chemoradiation-first patient may still meet the surgeon. Second, the functional column is where personal values enter. A singer, a teacher, a cook and a retired mechanic may weigh dry mouth against shoulder stiffness very differently, and the multidisciplinary meeting is designed to hear that.

What the table cannot show is timing. Postoperative radiotherapy is generally planned to begin once wounds have healed, and teams try not to let that interval stretch, because the evidence favors keeping the overall treatment package compact.

What the first days and weeks after treatment usually look like

After a neck dissection, the first thing most people notice is the drain: a thin tube under the skin that empties fluid into a small bottle and usually comes out before discharge. The neck feels tight and the skin below the ear may be numb, sometimes permanently. A physiotherapist visits early to start shoulder exercises, because even a nerve that was carefully preserved can be sluggish for weeks, and stiffness sets in quickly if the arm is left idle. Most people walk the same day. The pathology report on the removed nodes typically arrives in time for the first clinic visit, and that appointment is where the next step, often radiotherapy, is confirmed.

After radiotherapy, the hardest stretch is frequently the final week of treatment and the two or three weeks after it, when the mouth is sorest and eating is most difficult. This catches people out, because they expect to feel better the moment the sessions stop. Pain control, mouth care, a soft or liquid diet and close contact with the dietitian carry people through. Taste begins to return over weeks; saliva recovers more slowly and may never fully return. Swallowing exercises prescribed by the speech and language therapist are not optional homework; keeping the muscles moving during and after treatment is the main defence against long-term narrowing of the throat.

Follow-up begins almost immediately. The team examines the neck and throat at regular visits, most frequently in the first couple of years, and arranges the PET-CT at around 12 weeks after chemoradiation to judge whether the nodes have cleared. Thyroid function is checked periodically if the gland was in the radiation field. Each visit is also a chance to raise new symptoms, and the next section explains which ones should not wait for a scheduled appointment.

What people often get wrong about lymph node involvement

The most common misunderstanding is that a positive node means the cancer is everywhere. It does not. Regional spread to the neck is a distinct category from distant metastasis, and head and neck cancers with nodal disease are treated with the intention of controlling them. Stage is a planning tool, not a verdict.

A second belief is that more surgery is always safer. The evidence pushed the field the other way. Radical dissections that removed the jugular vein, the neck muscle and the shoulder nerve were once routine; they left people with chronic pain and a dropped shoulder, and outcomes were no better than more selective operations for most patients. Removing the levels at risk, and no more, is now the standard.

A third mistake happens before diagnosis. A neck lump that shrinks after a course of antibiotics is sometimes assumed to have been an infection. Lymph nodes containing cancer can fluctuate in size too, and a lump that returns, or that persists for more than a few weeks in an adult, needs assessment rather than a second prescription.

Some people hear that HPV-positive cancers are easier to treat and conclude they are not serious. The staging system was changed because these cancers behave differently, not because they can be left alone. Trials that test whether treatment can be safely reduced for HPV-positive disease are ongoing; outside a trial, standard treatment still applies.

Finally, many assume that asking for a second opinion will offend the team or delay care. Head and neck specialists expect it, and a well-run tumor board already represents several opinions in one room. Asking how many clinicians have reviewed the plan is a fair question, and the answer is usually reassuring.

Questions to ask your care team before the plan is finalized

A written list helps, because appointments move quickly and the vocabulary is new. The questions below are the ones head and neck specialists say they wish more people asked. Take them in, pick the ones that matter to you, and bring someone to write down the answers.

  • Where exactly is the primary tumor, and has it been confirmed by biopsy? If it has not been found, what is the search plan?
  • What is my clinical stage, and what do the T and N parts mean for me specifically?
  • Was my cancer tested for HPV, and how does the result change the options?
  • Which levels of my neck are involved, and which levels will be treated even though they look clear?
  • Has my case been discussed at a multidisciplinary meeting, and which specialties were present?
  • If surgery is first, which type of neck dissection is planned, and which structures will be preserved?
  • What findings in the pathology report would lead you to add radiotherapy or chemotherapy afterward?
  • If radiation is first, what happens if a node is still present on the scan after treatment?
  • What will this plan mean for my voice, my swallowing, my shoulder and my teeth a year from now?
  • Do I need dental work, a feeding tube or a hearing test before treatment starts, and will that change the start date?
  • Is there a clinical trial I would be eligible for, and how would taking part differ from standard care?
  • Who do I call, day or night, if something goes wrong during treatment?

Notice that none of these ask the team to promise an outcome. Clinicians cannot honestly do that, and a team that is comfortable saying what the evidence shows, including where it is thin, is giving you the straight answer. The question to end on is the simplest: given everything you know about me, what would you want to understand before saying yes to this plan?

When to call your doctor

Treatment for nodal disease in the neck involves the airway, the big vessels of the neck and the swallowing passage, so some warning signs need a same-day call and a few need emergency services. The team will give you a direct number before you go home; keep it in your phone and use it. Calling about something that turns out to be minor is never the wrong decision.

Call emergency services if breathing becomes difficult or noisy, if the neck swells rapidly, if there is heavy bleeding from the mouth or the wound, or if you cannot swallow your own saliva. These can signal bleeding or swelling near the airway and are treated as emergencies.

Call the cancer team the same day for a fever, which during chemotherapy can indicate a dangerously low white cell count and is always treated as urgent; for a wound that opens, becomes red and hot, or starts leaking cloudy or milky fluid; for new numbness or weakness in the face, arm or shoulder; for pain that stops you from drinking; or for signs of dehydration during radiotherapy such as dizziness, very dark urine, confusion or an inability to keep fluids down for a day. Mouth soreness that prevents eating for more than a day or two also deserves a call rather than endurance.

After treatment has finished, report any new lump in the neck, a sore or ulcer in the mouth that does not heal, a change in the voice lasting more than a few weeks, difficulty swallowing that is getting worse rather than better, ear pain on one side without an ear infection, or unexplained weight loss. None of these confirms anything on its own, and the team would far rather look and find nothing than find out late.

Every decision described in this article belongs to the people treating you. Use this guide to understand their reasoning and to ask better questions, not to replace it.

Frequently asked questions

Does lymph node involvement in neck cancer automatically mean stage 4?

No. The stage depends on how many nodes are involved, their size, whether they sit on one side or both, and whether cancer has broken through the node capsule, combined with the size of the primary tumor and the absence of distant spread. HPV-positive oropharyngeal cancers are staged on a separate scale, so several involved nodes can still correspond to an earlier stage. Your team can show you exactly how your T and N findings were combined.

What is neck dissection surgery, and will I definitely need one?

Neck dissection surgery removes lymph nodes and surrounding fatty tissue from selected levels of the neck under general anesthesia. Whether you need one depends on where the primary tumor is and whether the plan starts with surgery or radiation. For many oral cavity cancers it is standard; for many throat cancers treated with chemoradiation it is held in reserve for nodes that do not clear on the follow-up scan.

Can radiotherapy for neck lymph nodes replace surgery completely?

In many cases, yes. For cancers of the oropharynx and some larynx cancers, radiotherapy, often combined with chemotherapy, is the main treatment and covers the involved and at-risk neck levels in the same field. A PET-CT around 12 weeks after treatment then checks whether the nodes have resolved. Surgery is planned only if the scan remains suspicious, which spares most people an operation.

How is head and neck cancer staging done if the primary tumor cannot be found?

The node biopsy still gives the cell type and HPV status, which point toward the likeliest hidden site. Teams then examine the throat under anesthesia with biopsies of the base of tongue and other folds, often remove the tonsils for examination, and use PET-CT to look for small areas of uptake. If nothing is found, the cancer is treated as a squamous neck cancer with occult primary, following published guidance for that situation.

What does extranodal extension mean on my pathology report?

Extranodal extension means cancer cells have grown through the capsule of a lymph node into the surrounding tissue. It is reported by the pathologist after surgery and sometimes suspected by a radiologist on a scan. Guidelines treat it as a high-risk feature, and it is one of the main reasons a team recommends chemotherapy alongside postoperative radiotherapy rather than radiotherapy alone.

Why does the dentist need to see me before radiotherapy to the neck?

Jawbone that lies within the radiation field heals poorly for years afterward, so a tooth extraction done later carries a risk of bone that fails to heal. The dentist identifies teeth likely to cause trouble and removes them before treatment, allowing time for the sockets to heal. The visit also sets up fluoride care and mouth hygiene for the long term, because reduced saliva after radiotherapy raises the risk of decay.

How long does neck cancer treatment planning take before treatment starts?

The planning period is the time needed to complete the biopsy, scans, any examination under anesthesia, the dental and nutrition assessments and the multidisciplinary meeting. It varies with how quickly the primary tumor is found and whether dental extractions or a feeding tube are needed first. Teams aim to keep this phase as short as it safely can be, and your coordinator or specialist nurse can give you a realistic timeline for your own case.

Will my shoulder be affected after neck dissection surgery?

It can be. The spinal accessory nerve, which powers the muscle that lifts the shoulder, runs through the levels most often dissected. Surgeons preserve it whenever disease allows, but even a preserved nerve can be bruised and recover slowly over weeks to months. Early physiotherapy and daily exercises are the main way to limit stiffness, so ask when to start and keep going even on days when the neck feels tight.

What is a sentinel lymph node biopsy for cancer in the neck?

A sentinel lymph node biopsy removes only the first node or nodes that drain the tumor, identified by injecting a tracer around the cancer and following where it travels. It is used for selected early cancers of the mouth where the neck looks clear on examination and imaging. If the sentinel node is free of cancer, a full neck dissection can often be avoided; if it contains cancer, a dissection follows.

What happens if a lymph node is still swollen after chemoradiation?

A node that is still palpable right after treatment is common, because irradiated tissue takes time to shrink. Teams usually arrange a PET-CT at around 12 weeks after treatment ends; if the scan shows no active uptake, the node is watched. If uptake persists or the scan is equivocal, a neck dissection is planned. This approach was tested in a large randomized trial and is now standard practice.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 9, 2026 Last updated October 5, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.